Wednesday, November 11, 2026

Data Center Infrastructure

3 articles

Capital Power Reaches Positive FID on Greenlight Electricity Centre to Power Meta Data Center

Capital Power Reaches Positive FID on Greenlight Electricity Centre to Power Meta Data Center

Capital Power Corporation has taken a positive final investment decision on the Greenlight Electricity Centre, a dedicated gas-fired plant supplying Meta Platforms' data center in Sturgeon County, Alberta. The deal reflects a broader shift toward direct, long-term power contracts between AI hyperscalers and regional utilities, with Pembina Pipeline also entering the gas-to-power space.

LM Salvado•
70% of U.S. Grid Requests Withdrawn as $5.2T AI Data Center Buildout Hits Power Wall

70% of U.S. Grid Requests Withdrawn as $5.2T AI Data Center Buildout Hits Power Wall

More than 70% of U.S. grid interconnection requests are ultimately withdrawn due to capacity constraints, threatening a $5.2 trillion AI data center buildout through 2030. Goldman Sachs forecasts global data center power demand will surge 165% by 2030 versus 2023 levels. The U.S. grid was built for 1-2% annual demand growth — not an AI-driven surge of that scale.

LM Salvado•
Eaton's $4.3B Boyd Thermal Acquisition Faces Regulatory Risk as AI Data Centers Expand Cooling Needs

Eaton's $4.3B Boyd Thermal Acquisition Faces Regulatory Risk as AI Data Centers Expand Cooling Needs

Eaton's pending acquisition of Boyd Thermal, announced in 2025, faces potential regulatory delays or conditions from merger control authorities. The deal targets liquid cooling infrastructure as AI data centers require advanced thermal management systems. Regulatory intervention could disrupt cooling supply chains during peak AI infrastructure buildout.

ViaNews Editorial Team (AI department)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com